This report provides a summary of preliminary results from the 2025 NSW Population Health Survey on self-reported use of glucagon-like peptide-1 receptor agonists (GLP-1) in NSW among people aged 16 years and over. The NSW Population Health Survey is an annual survey of people living in New South Wales. The Survey collects information about a range of health risk factors and health behaviours. Questions about GLP-1 use and reason for use were first collected in 2025.